206 related articles for article (PubMed ID: 14973105)
1. HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.
Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):213-9. PubMed ID: 14973105
[TBL] [Abstract][Full Text] [Related]
2. CYP19 (aromatase) haplotypes and endometrial cancer risk.
Paynter RA; Hankinson SE; Colditz GA; Kraft P; Hunter DJ; De Vivo I
Int J Cancer; 2005 Aug; 116(2):267-74. PubMed ID: 15800924
[TBL] [Abstract][Full Text] [Related]
3. Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies.
Feigelson HS; Cox DG; Cann HM; Wacholder S; Kaaks R; Henderson BE; Albanes D; Altshuler D; Berglund G; Berrino F; Bingham S; Buring JE; Burtt NP; Calle EE; Chanock SJ; Clavel-Chapelon F; Colditz G; Diver WR; Freedman ML; Haiman CA; Hankinson SE; Hayes RB; Hirschhorn JN; Hunter D; Kolonel LN; Kraft P; LeMarchand L; Linseisen J; Modi W; Navarro C; Peeters PH; Pike MC; Riboli E; Setiawan VW; Stram DO; Thomas G; Thun MJ; Tjonneland A; Trichopoulos D
Cancer Res; 2006 Feb; 66(4):2468-75. PubMed ID: 16489054
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in the HSD17B1 gene and risk of prostate cancer.
Kraft P; Pharoah P; Chanock SJ; Albanes D; Kolonel LN; Hayes RB; Altshuler D; Andriole G; Berg C; Boeing H; Burtt NP; Bueno-de-Mesquita B; Calle EE; Cann H; Canzian F; Chen YC; Crawford DE; Dunning AM; Feigelson HS; Freedman ML; Gaziano JM; Giovannucci E; Gonzalez CA; Haiman CA; Hallmans G; Henderson BE; Hirschhorn JN; Hunter DJ; Kaaks R; Key T; Le Marchand L; Ma J; Overvad K; Palli D; Pike MC; Riboli E; Rodriguez C; Setiawan WV; Stampfer MJ; Stram DO; Thomas G; Thun MJ; Travis R; Trichopoulou A; Virtamo J; Wacholder S
PLoS Genet; 2005 Nov; 1(5):e68. PubMed ID: 16311626
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.
Haiman CA; Dossus L; Setiawan VW; Stram DO; Dunning AM; Thomas G; Thun MJ; Albanes D; Altshuler D; Ardanaz E; Boeing H; Buring J; Burtt N; Calle EE; Chanock S; Clavel-Chapelon F; Colditz GA; Cox DG; Feigelson HS; Hankinson SE; Hayes RB; Henderson BE; Hirschhorn JN; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Le Marchand L; Lenner P; Lund E; Panico S; Peeters PH; Pike MC; Riboli E; Tjonneland A; Travis R; Trichopoulos D; Wacholder S; Ziegler RG
Cancer Res; 2007 Mar; 67(5):1893-7. PubMed ID: 17325027
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor beta (ESR2 ) polymorphisms and endometrial cancer (United States).
Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
Cancer Causes Control; 2004 Aug; 15(6):627-33. PubMed ID: 15280642
[TBL] [Abstract][Full Text] [Related]
7. Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant.
Obazee O; Justenhoven C; Winter S; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Hannelius U; Li J; Humphreys K; Hall P; Giles G; Severi G; Baglietto L; Southey M; Rabstein S; Harth V; Lotz A; Pesch B; Brüning T; Baisch C; Ko YD; Hamann U; Brauch H
Breast Cancer Res Treat; 2013 Apr; 138(2):543-8. PubMed ID: 23430226
[TBL] [Abstract][Full Text] [Related]
8. HSD17B1 and CYP17 polymorphisms and breast cancer risk among Chinese women in Singapore.
Wu AH; Seow A; Arakawa K; Van Den Berg D; Lee HP; Yu MC
Int J Cancer; 2003 Apr; 104(4):450-7. PubMed ID: 12584742
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in genes involved in the estrogen pathway and mammographic density.
Dumas I; Diorio C
BMC Cancer; 2010 Nov; 10():636. PubMed ID: 21092186
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in genes hydroxysteroid-dehydrogenase-17b type 2 and type 4 and endometrial cancer risk.
Karageorgi S; McGrath M; Lee IM; Buring J; Kraft P; De Vivo I
Gynecol Oncol; 2011 Apr; 121(1):54-8. PubMed ID: 21129770
[TBL] [Abstract][Full Text] [Related]
11. HSD17B1 genetic variants and hormone receptor-defined breast cancer.
Gaudet MM; Chanock S; Dunning A; Driver K; Brinton LA; Lissowska J; Peplonska B; Pharoah P; Garcia-Closas M
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2766-72. PubMed ID: 18843021
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal estrogen monotherapy-associated breast cancer risk is modified by CYP17A1_-34_T>C polymorphism.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Apr; 120(3):737-44. PubMed ID: 19672705
[TBL] [Abstract][Full Text] [Related]
13. Interaction between CYP19A1 polymorphisms and body mass index in the risk of endometrial cancer in postmenopausal Japanese women.
Hosono S; Matsuo K; Ito H; Watanabe M; Hirose K; Nakanishi T; Tajima K; Tanaka H
Asian Pac J Cancer Prev; 2011; 12(10):2747-52. PubMed ID: 22320986
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 1B1 gene polymorphisms and postmenopausal endometrial cancer risk.
Rylander-Rudqvist T; Wedrén S; Jonasdottir G; Ahlberg S; Weiderpass E; Persson I; Ingelman-Sundberg M
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1515-20. PubMed ID: 15342454
[TBL] [Abstract][Full Text] [Related]
15. Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers.
Brown SB; Hankinson SE
Steroids; 2015 Jul; 99(Pt A):8-10. PubMed ID: 25555473
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms associated with circulating sex hormone levels in postmenopausal women.
Dunning AM; Dowsett M; Healey CS; Tee L; Luben RN; Folkerd E; Novik KL; Kelemen L; Ogata S; Pharoah PD; Easton DF; Day NE; Ponder BA
J Natl Cancer Inst; 2004 Jun; 96(12):936-45. PubMed ID: 15199113
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in CYP11A1 and StAR in relation to endometrial cancer risk.
Terry K; McGrath M; Lee IM; Buring J; De Vivo I
Gynecol Oncol; 2010 May; 117(2):255-9. PubMed ID: 20199803
[TBL] [Abstract][Full Text] [Related]
18. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review.
Olson SH; Bandera EV; Orlow I
Am J Epidemiol; 2007 Feb; 165(3):235-45. PubMed ID: 17110639
[TBL] [Abstract][Full Text] [Related]
19. UGT1A1 genetic polymorphisms, endogenous estrogen exposure, soy food intake, and endometrial cancer risk.
Deming SL; Zheng W; Xu WH; Cai Q; Ruan Z; Xiang YB; Shu XO
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):563-70. PubMed ID: 18349273
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk.
Rylander-Rudqvist T; Wedren S; Granath F; Humphreys K; Ahlberg S; Weiderpass E; Oscarson M; Ingelman-Sundberg M; Persson I
Carcinogenesis; 2003 Sep; 24(9):1533-9. PubMed ID: 12844487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
